Evidence map›Paper›PMID 25806028›Full record

ArticleFrontiers in microbiology2015

Calomys callosus chronically infected by Toxoplasma gondii clonal type II strain and reinfected by Brazilian strains is not able to prevent vertical transmission.

Priscila S Franco, Neide M da Silva, Bellisa de Freitas Barbosa, Angelica de Oliveira Gomes, Francesca Ietta, E K Shwab, Chunlei Su, José R Mineo, Eloisa A V Ferro

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Veterinary sciences · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Pathogens (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Congenital Transmission ofFrontiers in veterinary science · 2019
    Article
  10. Cyclooxygenase (COX)-2 Inhibitors ReduceFrontiers in microbiology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Priscila S FrancoLaboratory of Immunophysiology of Reproduction, Department of Histology and Embryology, Federal University of Uberlândia , Uberlândia, Brazil.
Neide M da SilvaLaboratory of Immunopathology, Institute of Biomedical Sciences, Federal University of Uberlândia , Uberlândia, Brazil.
Bellisa de Freitas BarbosaLaboratory of Immunophysiology of Reproduction, Department of Histology and Embryology, Federal University of Uberlândia , Uberlândia, Brazil.
Angelica de Oliveira GomesLaboratory of Immunophysiology of Reproduction, Department of Histology and Embryology, Federal University of Uberlândia , Uberlândia, Brazil.
Francesca IettaDepartment of Life Sciences, University of Siena , Siena, Italy.
E K ShwabDepartment of Microbiology, The University of Tennessee , Knoxville, TN, USA.
Chunlei SuDepartment of Microbiology, The University of Tennessee , Knoxville, TN, USA.
José R MineoLaboratory of Immunoparasitology, Department of Immunology, Microbiology and Parasitology, Federal University of Uberlândia , Uberlândia, Brazil.
Eloisa A V FerroLaboratory of Immunophysiology of Reproduction, Department of Histology and Embryology, Federal University of Uberlândia , Uberlândia, Brazil.
Universidade Federal de Uberlândia · BRUniversity of Tennessee at Knoxville · USUniversity of Siena · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering that Toxoplasma gondii has shown high genetic diversity in Brazil, the aim of this study was to determine whether Calomys callosus chronically infected by the ME-49 strain might be susceptible to reinfection by these Brazilian strains, including vertical transmission of the parasite. Survival curves were analyzed in non-pregnant females chronically infected with ME-49 and reinfected with the TgChBrUD1 or TgChBrUD2 strain, and vertical transmission was analyzed after reinfection of pregnant females with these same strains. On the 19th day of pregnancy (dop), placentas, uteri, fetuses, liver, spleen, and lung were processed for detection of the parasite. Blood samples were collected for humoral and cellular immune response analyses. All non-pregnant females survived after reinfection and no changes were observed in body weight and morbidity scores. In pregnant females, parasites were detected in the placentas of ME-49 chronically infected females and reinfected females, but were only detected in the fetuses of reinfected females. TgChBrUD2 reinfected females showed more impaired pregnancy outcomes, presenting higher numbers of animals with fetal loss and a higher resorption rate, in parallel with higher levels of pro-inflammatory cytokines and IgG2a subclass antibodies. Vertical transmission resulting from chronic infection of immunocompetent C. callosus is considered a rare event, being attributed instead to either reactivation or reinfection. That is, the pregnancy may be responsible for reactivation of the latent infection or the reinfection may promote T. gondii vertical transmission. Our results clearly demonstrate that, during pregnancy, protection against T. gondii can be breached after reinfection with parasites belonging to different genotypes, particularly when non-clonal strains are involved in this process and in this case the reinfection promoted vertical transmission of both type II and Brazilian T. gondii strains.

Indexed as

Brazilian strainscongenital toxoplasmosisparasite genotypesreinfectionToxoplasma gondii

Identifiers

PMID25806028
PMCPMC4354403
OpenAlexW2005821042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.